0001178913-26-004469.txt : 20260909 0001178913-26-004469.hdr.sgml : 20260909 20260909163036 ACCESSION NUMBER: 0001178913-26-004469 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260909 DATE AS OF CHANGE: 20260909 EFFECTIVENESS DATE: 20260909 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BioLineRx Ltd. CENTRAL INDEX KEY: 0001498403 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-596873 FILM NUMBER: 261368507 BUSINESS ADDRESS: ADDRESS IS A NON US LOCATION: YES STREET 1: 2 HAMAAYAN STREET STREET 2: MODI-IN TECHNOLOGY PARK CITY: MODI-IN PROVINCE COUNTRY: L3 ZIP: ISRAEL BUSINESS PHONE: 972-8-642-9100 MAIL ADDRESS: ADDRESS IS A NON US LOCATION: YES STREET 1: 2 HAMAAYAN STREET STREET 2: MODI-IN TECHNOLOGY PARK CITY: MODI-IN PROVINCE COUNTRY: L3 ZIP: ISRAEL FORMER COMPANY: FORMER CONFORMED NAME: BioLineRX, Ltd. DATE OF NAME CHANGE: 20100805 D 1 primary_doc.xml X0708 D LIVE 0001498403 BioLineRx Ltd. 2 HAMA'AYAN STREET MODI'IN L3 ISRAEL 7177871 972-8-642-9100 ISRAEL None BioLineRX, Ltd. Corporation true Philip A. Serlin BioLineRx Ltd. 2 HaMa'ayan Street Modi'in L3 ISRAEL 7177871 Executive Officer Chief Executive Officer Mali Zeevi BioLineRx Ltd. 2 HaMa'ayan Street Modi'in L3 ISRAEL 7177871 Executive Officer Chief Financial Officer Ella Sorani BioLineRx Ltd. 2 HaMa'ayan Street Modi'in L3 ISRAEL 7177871 Executive Officer Chief Development Officer Aharon Schwartz BioLineRx Ltd. 2 HaMa'ayan Street Modi'in L3 ISRAEL 7177871 Director Rami Dar BioLineRx Ltd. 2 HaMa'ayan Street Modi'in L3 ISRAEL 7177871 Director BJ Bormann BioLineRx Ltd. 2 HaMa'ayan Street Modi'in L3 ISRAEL 7177871 Director Raphael Hofstein BioLineRx Ltd. 2 HaMa'ayan Street Modi'in L3 ISRAEL 7177871 Director Avraham Molcho BioLineRx Ltd. 2 HaMa'ayan Street Modi'in L3 ISRAEL 7177871 Director Sandra Panem BioLineRx Ltd. 2 HaMa'ayan Street Modi'in L3 ISRAEL 7177871 Director Shaoyu Yan BioLineRx Ltd. 2 HaMa'ayan Street Modi'in L3 ISRAEL 7177871 Director Gal Cohen BioLineRx Ltd. 2 HaMa'ayan Street Modi'in L3 ISRAEL 7177871 Director Biotechnology Decline to Disclose 06b false 2026-08-27 false true true false 0 Chardan Capital Markets LLC 000120128 None None 1 Pennsylvania Plaza, Suite 4800 NEW YORK NY NEW YORK 10119 NY NEW YORK false 3750000 3750000 0 The securities were issued in connection with an offering of (i) 480,696 American depositary shares (ADSs) and 868,225 pre-funded warrants to purchase ADSs in a registered direct offering, and (ii) unregistered warrants to purchase 2,023,382 ADSs. false 1 262500 0 Chardan is also entitled to 1.0% of the gross proceeds as management fee and $50,000 for accountable expenses. 0 The Company intends to use the net proceeds or research and development activities and working capital and general corporate purposes. false BioLineRx Ltd. /s/ Mali Zeevi Mali Zeevi Chief Financial Officer 2026-09-09